Skip to main content
Erschienen in: Skeletal Radiology 2/2017

25.11.2016 | Case Report

MRI in flexor tendon rupture after collagenase injection

verfasst von: Shruti Khurana, Vibhor Wadhwa, Avneesh Chhabra, Bardia Amirlak

Erschienen in: Skeletal Radiology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Flexor tendon rupture is an unusual complication following collagenase injection to relieve contractures. These patients require a close follow-up and in the event of tendon rupture, a decision has to be made whether to repair the tendon or manage the complication conservatively. The authors report the utility of MRI in the prognostication and management of a patient with Dupuytren’s contracture, who underwent collagenase injection and subsequently developed flexor digitorum profundus tendon rupture.
Literatur
1.
Zurück zum Zitat Wilburn J, McKenna SP, Perry-Hinsley D, Bayat A. The impact of Dupuytren disease on patient activity and quality of life. J Hand Surg [Am]. 2013;38(6):1209–14.CrossRef Wilburn J, McKenna SP, Perry-Hinsley D, Bayat A. The impact of Dupuytren disease on patient activity and quality of life. J Hand Surg [Am]. 2013;38(6):1209–14.CrossRef
2.
Zurück zum Zitat Gilpin D, Coleman S, Hall S, Houston A, Karrasch J, Jones N. Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren’s disease. J Hand Surg [Am]. 2010;35(12):2027–2038.e1.CrossRef Gilpin D, Coleman S, Hall S, Houston A, Karrasch J, Jones N. Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren’s disease. J Hand Surg [Am]. 2010;35(12):2027–2038.e1.CrossRef
3.
Zurück zum Zitat Coert JH, Nerin JP, Meek MF. Results of partial fasciectomy for Dupuytren disease in 261 consecutive patients. Ann Plast Surg. 2006;57(1):13–7.CrossRefPubMed Coert JH, Nerin JP, Meek MF. Results of partial fasciectomy for Dupuytren disease in 261 consecutive patients. Ann Plast Surg. 2006;57(1):13–7.CrossRefPubMed
4.
Zurück zum Zitat Zhang AY, Curtin CM, Hentz VR. Flexor tendon rupture after collagenase injection for Dupuytren contracture: case report. J Hand Surg [Am]. 2011;36(8):1323–5.CrossRef Zhang AY, Curtin CM, Hentz VR. Flexor tendon rupture after collagenase injection for Dupuytren contracture: case report. J Hand Surg [Am]. 2011;36(8):1323–5.CrossRef
5.
Zurück zum Zitat Povlsen B, Singh S. Acute double flexor tendon ruptures following injection of collagenase clostridium histolyticum (Xiapex) for Dupuytren’s contracture. BMJ Case Rep. 2014. 10.1136/bcr-2013-203338. Povlsen B, Singh S. Acute double flexor tendon ruptures following injection of collagenase clostridium histolyticum (Xiapex) for Dupuytren’s contracture. BMJ Case Rep. 2014. 10.​1136/​bcr-2013-203338.
7.
Zurück zum Zitat Picardo NE, Khan WS. Advances in the understanding of the aetiology of Dupuytren’s disease. Surgeon. 2012;10(3):151–8.CrossRefPubMed Picardo NE, Khan WS. Advances in the understanding of the aetiology of Dupuytren’s disease. Surgeon. 2012;10(3):151–8.CrossRefPubMed
8.
Zurück zum Zitat Sweet S, Blackmore S. Surgical and therapy update on the management of Dupuytren’s disease. J Hand Ther. 2014;27(2):77–83. quiz 4.CrossRefPubMed Sweet S, Blackmore S. Surgical and therapy update on the management of Dupuytren’s disease. J Hand Ther. 2014;27(2):77–83. quiz 4.CrossRefPubMed
9.
Zurück zum Zitat Syed F, Thomas AN, Singh S, Kolluru V, Emeigh Hart SG, Bayat A. In vitro study of novel collagenase (XIAFLEX®) on Dupuytren’s disease fibroblasts displays unique drug related properties. PLoS One. 2012;7(2):e31430.CrossRefPubMedPubMedCentral Syed F, Thomas AN, Singh S, Kolluru V, Emeigh Hart SG, Bayat A. In vitro study of novel collagenase (XIAFLEX®) on Dupuytren’s disease fibroblasts displays unique drug related properties. PLoS One. 2012;7(2):e31430.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Coleman S, Gilpin D, Kaplan FT, Houston A, Kaufman GJ, Cohen BM, et al. Efficacy and safety of concurrent collagenase clostridium histolyticum injections for multiple Dupuytren contractures. J Hand Surg [Am]. 2014;39(1):57–64.CrossRef Coleman S, Gilpin D, Kaplan FT, Houston A, Kaufman GJ, Cohen BM, et al. Efficacy and safety of concurrent collagenase clostridium histolyticum injections for multiple Dupuytren contractures. J Hand Surg [Am]. 2014;39(1):57–64.CrossRef
11.
Zurück zum Zitat Badalamente MA, Hurst LC, Benhaim P, Cohen BM. Efficacy and safety of collagenase clostridium histolyticum in the treatment of proximal interphalangeal joints in Dupuytren contracture: combined analysis of 4 phase 3 clinical trials. J Hand Surg [Am]. 2015;40(5):975–83.CrossRef Badalamente MA, Hurst LC, Benhaim P, Cohen BM. Efficacy and safety of collagenase clostridium histolyticum in the treatment of proximal interphalangeal joints in Dupuytren contracture: combined analysis of 4 phase 3 clinical trials. J Hand Surg [Am]. 2015;40(5):975–83.CrossRef
12.
Zurück zum Zitat Watt AJ, Curtin CM, Hentz VR. Collagenase injection as nonsurgical treatment of Dupuytren’s disease: 8-year follow-up. J Hand Surg [Am]. 2010;35(4):534–9, 539.e1.CrossRef Watt AJ, Curtin CM, Hentz VR. Collagenase injection as nonsurgical treatment of Dupuytren’s disease: 8-year follow-up. J Hand Surg [Am]. 2010;35(4):534–9, 539.e1.CrossRef
13.
Zurück zum Zitat Crivello KM, Potter HG, Moon ES, Rancy SK, Wolfe SW. Does collagenase injection disrupt or digest the Dupuytren’s cord: a magnetic resonance imaging study. J Hand Surg Eur Vol. 2016;41(6):614–20.CrossRefPubMed Crivello KM, Potter HG, Moon ES, Rancy SK, Wolfe SW. Does collagenase injection disrupt or digest the Dupuytren’s cord: a magnetic resonance imaging study. J Hand Surg Eur Vol. 2016;41(6):614–20.CrossRefPubMed
14.
Zurück zum Zitat Hayton MJ, Bayat A, Chapman DS, Gerber RA, Szczypa PP. Isolated and spontaneous correction of proximal interphalangeal joint contractures in Dupuytren’s disease: an exploratory analysis of the efficacy and safety of collagenase Clostridium histolyticum. Clin Drug Investig. 2013;33(12):905–12.CrossRefPubMedPubMedCentral Hayton MJ, Bayat A, Chapman DS, Gerber RA, Szczypa PP. Isolated and spontaneous correction of proximal interphalangeal joint contractures in Dupuytren’s disease: an exploratory analysis of the efficacy and safety of collagenase Clostridium histolyticum. Clin Drug Investig. 2013;33(12):905–12.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Peimer CA, Wilbrand S, Gerber RA, Chapman D, Szczypa PP. Safety and tolerability of collagenase Clostridium histolyticum and fasciectomy for Dupuytren’s contracture. J Hand Surg Eur Vol. 2015;40(2):141–9.CrossRefPubMedPubMedCentral Peimer CA, Wilbrand S, Gerber RA, Chapman D, Szczypa PP. Safety and tolerability of collagenase Clostridium histolyticum and fasciectomy for Dupuytren’s contracture. J Hand Surg Eur Vol. 2015;40(2):141–9.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Lee DH, Han SB, Park JW, Lee SH, Kim KW, Jeong WK. Sonographically guided tendon sheath injections are more accurate than blind injections: implications for trigger finger treatment. J Ultrasound Med. 2011;30(2):197–203.PubMed Lee DH, Han SB, Park JW, Lee SH, Kim KW, Jeong WK. Sonographically guided tendon sheath injections are more accurate than blind injections: implications for trigger finger treatment. J Ultrasound Med. 2011;30(2):197–203.PubMed
17.
Zurück zum Zitat Bianchi S, Martinoli C, de Gautard R, Gaignot C. Ultrasound of the digital flexor system: normal and pathological findings(). J Ultrasound. 2007;10(2):85–92.CrossRefPubMedPubMedCentral Bianchi S, Martinoli C, de Gautard R, Gaignot C. Ultrasound of the digital flexor system: normal and pathological findings(). J Ultrasound. 2007;10(2):85–92.CrossRefPubMedPubMedCentral
Metadaten
Titel
MRI in flexor tendon rupture after collagenase injection
verfasst von
Shruti Khurana
Vibhor Wadhwa
Avneesh Chhabra
Bardia Amirlak
Publikationsdatum
25.11.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Skeletal Radiology / Ausgabe 2/2017
Print ISSN: 0364-2348
Elektronische ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-016-2524-2

Weitere Artikel der Ausgabe 2/2017

Skeletal Radiology 2/2017 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.